CTI BioPharma (CTIC) Q2 2014 Results - Earnings Call Webcast

Aug. 4.14 | About: CTI BioPharma (CTIC)

CTI BioPharma (NASDAQ:CTIC): Q2 EPS of -$0.19 Revenue of $1.3M (+282.4% Y/Y)

The following audio is from a conference call that will begin on August 04, 2014 at 16:30 PM ET. The audio will stream live while the call is active, and can be replayed upon its completion.

If you would like to view a transcript of this call, please click here.